Investor Relations
Corporate Profile
Cerevel Therapeutics is tackling neuroscience diseases with a differentiated approach that combines expertise in NEUROCIRCUITRY with a focus on receptor SELECTIVITY
Financial Metrics
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Cerevel is now part of AbbVie
Together we will deliver science that takes us closer to meaningful change for people with neurological and psychiatric disorders.